Diabetes in South and Central America: an update
- PMID: 24439209
- DOI: 10.1016/j.diabres.2013.11.010
Diabetes in South and Central America: an update
Abstract
The estimated population of the South and Central America (SACA) Region is 467.6 million and 64% is in the age range of 20-79 years but the population pyramid and age distribution are changing. The average prevalence of diabetes in the Region is 8.0% and is expected to reach 9.8% by the year 2035. Prevalence is much lower in rural settings than in urban and the differences attributed to lifestyle changes may be a target for intervention. The indigenous population is a particularly vulnerable group needing special attention. On average, 24% of the adult cases with diabetes are undiagnosed but in some countries this is still as high as 50%. Health expenditure due to diabetes in the Region is around 9% of the global total. Inadequate glycemic control, defined as HbA1c >7%, is a strong predictor of chronic complications which increase resource use in the Region and less than half of the patients enrolled in diabetes care programmes are at target. Fifty percent or more of the adult population is overweight/obese and around one third of the adult population has metabolic syndrome using regional cutoffs for waist circumference. The number of people with IGT is almost equal to those with diabetes presenting an additional challenge for prevention. Children with type 1 diabetes represent only 0.2% of the total population with diabetes but the incidence may be increasing. In many places they have limited access to insulin, and even when available, it is not used appropriately. The available epidemiological data provide the background to act in developing national diabetes programmes which integrate diabetes care with cardiovascular prevention and promote diabetes prevention as well.
Keywords: Diabetes; Glycemic control; HbA1c; Impaired Glucose Tolerance; Prevalance; South and Central America.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
[Epidemiology of diabetes mellitus in South America: The experience of Colombia].Clin Investig Arterioscler. 2016 Sep-Oct;28(5):245-256. doi: 10.1016/j.arteri.2015.12.002. Epub 2016 May 11. Clin Investig Arterioscler. 2016. PMID: 26949070 Spanish.
-
[Appearance of undiagnosed diabetes mellitus in the population of professionally active people in the urban areas].Pol Arch Med Wewn. 2001 Sep;106(3):815-21. Pol Arch Med Wewn. 2001. PMID: 11928591 Polish.
-
Insulin resistance and impaired glucose tolerance in overweight and obese Costa Rican schoolchildren.Food Nutr Bull. 2008 Jun;29(2):123-31. doi: 10.1177/156482650802900206. Food Nutr Bull. 2008. PMID: 18693476
-
Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.Pharmacoeconomics. 2004;22(6):389-411. doi: 10.2165/00019053-200422060-00005. Pharmacoeconomics. 2004. PMID: 15099124 Review.
-
The metabolic syndrome in South Asians: epidemiology, determinants, and prevention.Metab Syndr Relat Disord. 2009 Dec;7(6):497-514. doi: 10.1089/met.2009.0024. Metab Syndr Relat Disord. 2009. PMID: 19900153 Review.
Cited by
-
Corrigendum to: Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis Mobasseri M, Shirmohammadi M, Amiri T, Vahed N, Hosseini Fard H, Ghojazadeh M. Health Promot Perspect. 2020 Mar 30;10(2):98-115. doi: 10.34172/hpp.2020.18.Health Promot Perspect. 2024 Jul 29;14(2):202-205. doi: 10.34172/hpp.43143. eCollection 2024. Health Promot Perspect. 2024. PMID: 39291043 Free PMC article.
-
Survey on hypoglycemia among insulin-treated patients with diabetes: The Colombian International Operations Hypoglycemia Assessment Tool population.Biomedica. 2019 Sep 1;39(3):576-586. doi: 10.7705/biomedica.4365. Biomedica. 2019. PMID: 31584770 Free PMC article.
-
Metabolic control in patients with type 2 diabetes mellitus in a public hospital in Peru: a cross-sectional study in a low-middle income country.PeerJ. 2016 Oct 13;4:e2577. doi: 10.7717/peerj.2577. eCollection 2016. PeerJ. 2016. PMID: 27761351 Free PMC article.
-
Patients' Preference Between DPP4i and SGLT2i for Type 2 Diabetes Treatment: A Cross-Sectional Evaluation.Patient Prefer Adherence. 2022 May 9;16:1201-1211. doi: 10.2147/PPA.S355638. eCollection 2022. Patient Prefer Adherence. 2022. PMID: 35592774 Free PMC article.
-
Obese first-degree relatives of patients with type 2 diabetes with elevated triglyceride levels exhibit increased β-cell function.Metab Syndr Relat Disord. 2015 Feb;13(1):45-51. doi: 10.1089/met.2014.0095. Epub 2014 Nov 25. Metab Syndr Relat Disord. 2015. PMID: 25423015 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical